Skip to content

Author

O. de Backer

We have 11 of 638 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Transcatheter aortic valve implantation and need for post-discharge pacemaker implantation in the modern era of fast discharge

Up to 20% of transcatheter aortic valve implantations (TAVIs) are followed by post-procedural conduction disturbances. As next-day discharge is becoming standard of care, predictors of permanent high-degree conduction disturbances requiring permanent pacemaker implantation (PPMI) are of increasing clinical releva...

A. D. Haue, A. A. Raja, D. Hoefsten et al. · 0 citations
Open access Oct 2026

Influence of ascending aorta diameter on short- and long-term clinical outcomes after transcatheter aortic valve implantation for bicuspid aortic valve stenosis

Bicuspid aortic valve (BAV) stenosis has been associated with challenging anatomical features for transcatheter aortic valve implantation (TAVI). Ascending aorta dilatation is frequently observed in patients with BAV stenosis and its implications for TAVI outcomes remain undetermined. To assess short and l...

D. Giacoppo, H. Alvarez Covarrubias, T. Pilgrim et al. · 0 citations
Oct 2026

Timing of revascularisation in patients undergoing high-risk percutaneous coronary intervention and Transcatheter aortic valve implantation: insights from the ASCoP registry.

BACKGROUND Evidence on the management of complex and high-risk coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI) is still limited. In particular, the optimal timing of percutaneous coronary intervention (PCI) relative to TAVI remains uncertain. METHODS The ASCop is an...

A. Munafò, Giuseppe Esposito, A. Khokhar et al. · 0 citations
Open access Aug 2026

Comparison of Health Status After TAVI and SAVR in Younger Low-Risk Patients with Aortic Stenosis: a NOTION-2 Analysis

Several trials have shown that transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) yield non-inferior short- and mid-term clinical outcomes in low surgical risk patients. However, information on the health status achieved by these patients is lacking. To compare the...

A. Phoksiri, A. Maznyczka, M. Savontaus et al. · 1 citation
Open access Sep 2026

Clinical Outcomes and Valve Performance of Intra-Annular Self-Expanding Transcatheter Aortic Valve in Valve-in-Valve Procedures: Insights From the NAViV Registry.

BACKGROUND Most evidence for transcatheter aortic valve replacement (TAVR) for valve-in-valve procedures comes from balloon-expandable and supra-annular self-expanding valves. However, data on intra-annular self-expanding valves remain limited. The objectives of this registry were to evaluate the short- and midterm out...

Jorge F. Chavez, G. Tirado-Conte, Y. Kobari et al. · 0 citations
Sep 2026

Impact of Initial Valve Type on Reintervention for TAVR Failure: From the EXPLANTORREDO-TAVR International Registry.

BACKGROUND As transcatheter aortic valve replacement (TAVR) expands to younger patients, there is limited data on the impact of TAV type on outcomes of TAVR-explant and redo-TAVR for TAVR failure. We sought to compare outcomes of reintervention for failed balloon-expandable valves (BEV) versus self-expanding valves (SE...

Syed Zaid, Tsuyoshi Kaneko, O. de Backer et al. · 0 citations
Open access Aug 2026

Prognostic Impact of Kidney Function before Transcatheter Aortic Valve Implantation - A Nationwide study

Prognosis after transcatheter aortic valve implantation (TAVI) keeps improving, yet some high-risk groups persist with chronic kidney disease being one. Contemporary data on the prognostic importance of pre-TAVI kidney function are sparse, leaving uncertainty regarding which patients derive limited benefit from T...

Martha Meibom, J. Petersen, Victoria Mikkelsen et al. · 0 citations
Open access Sep 2026

Multimodality imaging for pre-, intra-, and postprocedural guidance of left atrial appendage closure: a European Left Atrial Appendage Closure Club (ELAACC) expert consensus statement.

Left atrial appendage closure (LAAC) is an established alternative for stroke prevention in patients with non-valvular atrial fibrillation who are not suitable candidates for long-term oral anticoagulation. Imaging is central to procedural success and safety, yet variability in acquisition, measurement, and reporting c...

Nina C. Wunderlich, Laura Sanchis Ruiz, Adel Aminian et al. · 0 citations
Sep 2026

Clinical Outcomes of a Dedicated TAVR Device for Native Aortic Regurgitation: Insights From a Multicenter Real-World Experience.

BACKGROUND The JenaValve Trilogy Transcatheter Heart Valve System (Trilogy) is a CE-marked transcatheter aortic valve replacement device designed for the treatment of symptomatic aortic regurgitation. Despite its unique indication, data from large cohorts remain limited. This study aimed to evaluate procedural characte...

H. Wienemann, Sara Yousefzada, M. Rogmann et al. · 0 citations
Aug 2026

Outcomes of patients with large anatomies undergoing transcatheter tricuspid valve replacement with the LuX-Valve Plus system.

TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.

O. de Backer, Y. Lim, R. von Bardeleben et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.